J Endocrinol (2013) 219(1):5968.10.1530/JOE-13-0146 27 SunHXLuNLuoXZhaoLLiuJM
The most commonly reported are gastrointestinal symptoms like nausea, vomiting and diarrhoea
Its not a normal situation that a blockbuster drug immediately goes on shortage and meets criteria for compounding pharmacies to compound it, said Tenille Davis, an Arizona pharmacist and the chief advocacy officer for the Alliance of Pharmacy Compounding, an industry group representing compounding pharmacists
Ozempic Use Linked to Vision Loss and NAION Study Highlight: Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide In July 2024, researchers at Mass Eye and Ear found a potential link between the use of semaglutide and an increased risk of developing NAOIN, a rare but serious condition
2 Key Players In The GLP-1 Market Novo Nordisk Positioning: Novo Nordisk (Novo) is the undisputed leader in the GLP-1 receptor agonist market, largely due to the success of semaglutide, which is marketed as Ozempic for diabetes and Wegovy for weight management
Additionally, berberine and other patch ingredients can cause side effects such as: Upset stomach Diarrhea Constipation Excess gas The severity and duration of these side effects are uncertain, unlike GLP-1 injections, whose side effects are well-documented and tend to stabilize over time
